GlassScriptPhysician profile
Tami Mccoy
NPI 1952716136
$4,934.51
in general payments reported to CMS, 2019-2025
34 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $443 · 2023: $1,287 · 2024: $1,373 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,392 · Gift: $59.40 · Education: $40.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,391.62 |
| Gift | $59.40 |
| Education | $40.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $699.84 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $506.78 | 2022-2025 | Omnipod |
| Lilly USA, LLC | $475.34 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $346.02 | 2022-2025 | |
| Amgen INC. | $327.60 | 2024-2025 | Tepezza, Evenity |
| Corcept Therapeutics | $297.73 | 2023-2025 | Korlym |
| Mannkind Corporation | $288.98 | 2022-2025 | Afrezza |
| Radius Health, INC. | $197.01 | 2023-2025 | Tymlos |
| Abbott Laboratories | $172.56 | 2024-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $171.32 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $166.95 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.29 | 2023-2025 | Jardiance |
| Cequr Corporation | $123.86 | 2023-2025 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $122.12 | 2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $119.81 | 2023-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascensia Diabetes Care US INC. | $113.56 | 2023-2024 | |
| Sequel Med Tech, LLC | $103.31 | 2025 | Twiist |
| Amneal Pharmaceuticals LLC | $78.42 | 2022-2023 | Unithroid |
| Medtronic, INC. | $65.48 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $59.27 | 2022-2025 | Farxiga |
| Horizon Therapeutics Plc | $46.76 | 2023 | Tepezza |
| Antares Pharma, INC. | $38.87 | 2025 | Xyosted |
| Madrigal Pharmaceuticals | $38.10 | 2025 | Rezdiffra |
| Alexion Pharmaceuticals, INC. | $36.47 | 2022-2025 | Strensiq |
| Beta Bionics, INC. | $27.43 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bigfoot Biomedical INC | $25.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.11 | 2025 | Trintellix |
| Ibsa Pharma INC. | $18.07 | 2023 | Tirosint, Licart |
| Kyowa Kirin, INC. | $17.89 | 2022 | |
| Almatica Pharma LLC | $17.48 | 2025 | Teriparatide |
| Exact Sciences Corporation | $16.54 | 2025 | Cologuard Collection Kit |
| Acella Pharmaceuticals, LLC | $14.84 | 2025 | NP Thyroid 60 |
| Pfizer INC. | $14.41 | 2025 | |
| Abbvie INC. | $14.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tami Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.